Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 221-240 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 221 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Only weak opportunity support is visible in these reviewed sources: membership rationale says the company completed a €180M Series C fundraising, but no representative article, no direct positive evidence, and no in-recent evidence window article detail are provided here, so there is not enough cited support to form a strong 1 year+ opportunity thesis. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 222 | Pilot Photonics lowweak | Opp 2 Risk 1 | Thesis: Membership rationale says Pilot Photonics secured a €1 million ESA contract for space photonics development and that the technology addresses satellite communication demands, which could support a modest long-horizon opportunity thesis if contract execution expands. Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window. Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction. |
| 223 | Pixxel lowweak | Opp 2 Risk 1 | Thesis: Pixxel has a plausible long-horizon opportunity narrative from an external article summary describing a Pixxel-led consortium winning an Indian EO constellation PPP, but that article is dated October 13, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current ranking thesis. Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025 Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available. |
| 224 | Reliance Industries Limited lowweak | Opp 2 Risk 2 | Thesis: There is a possible long-horizon opportunity if Reliance, via Jio Platforms, advances its described LEO satellite communications ambitions, but the reviewed sources does not retain representative article details, or within the recent evidence window evidence to ground that as a current high-conviction thesis. Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0. Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view. |
| 225 | Remondo lowweak | Opp 2 Risk 2 | Thesis: Older context suggests a potentially differentiated Earth-observation approach, with a first mission planned in 2027 to demonstrate a partial aperture imaging system, but this falls outside the active evidence recent evidence window and is insufficient for a strong current rank. Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis. Evidence
Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited. |
| 226 | Rhea Space Activity lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Rhea Space Activity raised about $6 million in Series A financing for GPS-denied navigation software targeting military and intelligence customers, which would be a constructive long-horizon signal if confirmed by available evidence, but this screen contains no usable within the recent evidence window evidence or article. Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested. Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence. |
| 227 | Rocket One, Inc. lowweak | Opp 2 Risk 2 | Thesis: Among this screen, Rocket One has the strongest contextual indication of a strategic pivot toward space/defense AI chips and nano-launch or nanosatellite enablement, which could become a long-horizon opportunity if later corroborated by direct execution evidence. However, these reviewed sources have no direct positive evidence inside the recent evidence window, so the thesis remains weak. Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering. |
| 228 | Rogue Space Systems lowweak | Opp 2 Risk 1 | Thesis: There is limited relevance support that Rogue Space Systems is an operating in-orbit servicing company, which is directionally compatible with a long-horizon commercial space opportunity view, but the evidence is only undated directory-style context and not direct positive operating proof. Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain. Evidence
Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included. |
| 229 | RTX Corporation lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources' membership rationale references involvement in U.S. Space Force and missile-warning programs, which could support long-horizon opportunity, but no within the recent evidence window direct evidence or representative article summaries are available for scoring in this screen. Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence. Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence. |
| 230 | Sanyark Space Technologies lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources places Sanyark Space Technologies in a spacetech accelerator among startups working on rocket propulsion, satellites, and space energy. That supports a possible early-stage opportunity setup, but the reviewed sources does not specify which activities belong to Sanyark itself and provides no direct evidence row or (: not provided in reviewed sources). Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure. Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available. |
| 231 | Satellogic Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale describes Satellogic as an Earth observation/geospatial company with constellation and monitoring contracts, which could be constructive over a 1 year+ horizon, but no available current evidence supports a stronger call. Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence. |
| 232 | SatixFy lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale references SatixFy as an Israeli chipmaker acquired by MDA Space with first space-grade chips shipped, which may indicate strategic relevance, but there are no retained in-window evidence here. Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone. Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence. |
| 233 | SatSure Analytics India Pvt. Ltd. lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence context indicates SatSure is developing a large Earth Observation AI model and received IN-SPACe Technology Adoption Fund support including a ₹24.6 crore grant, which could support longer-horizon capability building, but no direct post-recent evidence window evidence are available to validate timing, scale, or current business momentum in the next 1 year+ horizon. Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only. |
| 234 | SatVu lowweak | Opp 2 Risk 1 | Thesis: An external article says SatVu closed a £30m funding round, which is positive financing context, but that article is dated February 17, 2026 and was dropped by the 90-day recent evidence policy, so it cannot support a strong current opportunity ranking Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy. Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score. |
| 235 | Scale AI lowweak | Opp 2 Risk 1 | Thesis: Membership rationale says Scale AI received a U.S. Space Force Golden Dome contract as part of an approximately $3.2 billion award group, which, if current and durable, could support a meaningful public-sector space/defense opportunity over a 1 year+ horizon. Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope. Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion. |
| 236 | Schaeffler AG lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Schaeffler planned a collaboration with Spire on satellite bus manufacturing and RF sensing, which suggests strategic adjacency to space systems, but there is no available within the recent evidence window direct evidence to underwrite a durable opportunity thesis. Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence. Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources. |
| 237 | SEALCOIN AG lowweak | Opp 2 Risk 1 | Thesis: There is a hint of financing-related progress in space-based blockchain infrastructure, but the reviewed sources lack retained direct evidence strong enough to support a robust opportunity thesis. Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window. Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself. |
| 238 | Sidus Space Inc. lowweak | Opp 2 Risk 3 | Thesis: The membership rationale indicates Sidus Space operates LizzieSat satellites, manufacturing, and customer contracts, which could support a long-horizon operating-space-company thesis, but this screen includes no available within the recent evidence window article summaries or evidence to evaluate direction. Why now: Why now is weak because although the company had 44 considered articles, the reviewed sources show articles after recent evidence window = 0 and evidence after recent evidence window = 0, so the current business state is not evidenced here. Caveats: Phase-2 membership rationale references: and: but no or available evidence are provided. A large historical article universe should not be mistaken for conviction. No within the recent evidence window direct evidence is available for ranking. |
| 239 | Sift lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources hints at potential opportunity from Sift raising $42 million and building AI infrastructure for mission-critical hardware including space and defense, but no kept citable evidence or are provided here. Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon. Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence. |
| 240 | Silicon Microgravity lowweak | Opp 2 Risk 2 | Thesis: There is modest theoretical opportunity because the reviewed sources' membership rationale says Silicon Microgravity received £500K in UK space funding, but no reviewed evidence row or citable article is supplied here. Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary. Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence. |
Risk view
Showing rows 21-40 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 21 | Capella Space highstrong | Opp 8 Risk 4 | Thesis: Risk is present but not thesis-dominant: Capella is undertaking defense-oriented prototype work and broader strategic expansion beyond commercial SAR, which can carry execution complexity, but the reviewed sources contain no direct adverse evidence within the recent evidence window. Why now: The April 8, 2026 SDA award is recent within the recent evidence window and is directly relevant to a 1 year+ horizon because it funds spacecraft design and development for a government demonstration program. Later context articles in April-June 2026 continue to depict Capella as an operating SAR platform with defense exposure. Evidence
Caveats: The positive contract evidence is classified as a neutral supporting fact in the reviewed sources, so direction is inferred from the business substance rather than explicit positive polarity labeling. Several contextual articles mention a planned acquisition or subsidiary status, but time-sensitive ownership/public-status interpretations should be treated cautiously because not all such references are direct, dated transaction-closing evidence. For example, and |
| 22 | Cowboy Space mediummedium | Opp 7 Risk 4 | Thesis: Execution risk is meaningful because the business combines new rocket development with orbital data-center infrastructure, and one cited article says the first launch is expected before the end of 2028, implying a long path from capital raise to operational proof. Why now: Multiple dated articles on May 11, 2026 report Cowboy Space raised $275 million in Series B financing at a $2 billion valuation to build rockets with orbital data-center upper stages, and a TechCrunch article says the company is standing up its own rocket program with a first launch expected before end-2028 Evidence
Caveats: The reviewed sources contain no explicit negative event evidence; risk is inferred from execution complexity and long timeline, not from adverse events. Several supporting rows repeat the same May 11, 2026 financing story and are not independent confirmation. Some supporting article context is undated and should be treated cautiously for recency. |
| 23 | Eutelsat Communications SA mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the ranking payload contains no kept direct evidence or representative articles for those claims, so the thesis depends on membership-support statements without available article detail, economics, or recency granularity beyond inclusion in the recent evidence windowed reviewed sources. Why now: The reviewed sources' membership rationale cites current program/contract relevance through support articles 2026-04, and: but were not provided in the payload, limiting precise timing narration. Evidence
Caveats: The reviewed sources does not provide for the membership-support article IDs. Opportunity score is tempered by the absence of kept direct evidence in the ranking payload. |
| 24 | GalaxEye mediummedium | Opp 7 Risk 4 | Thesis: Risk remains meaningful because the reviewed sources does not provide direct evidence of post-launch operational performance, customer revenue conversion, or successful scaling beyond the first satellite. Funding references are inconsistent across articles, and planned next-round financing after commissioning indicates continued capital dependence. Why now: The key timing change is that earlier pre-launch coverage from April 23, 2026 was followed by launch coverage on May 3, 2026/May 4, 2026, and later June 16, 2026 context states the first satellite was launched in May 2026, confirming a business-state transition from concept/pre-launch to deployed asset status. The NSIL resale agreement was reported earlier on February 13, 2026, giving a potential go-to-market bridge once satellite data is available. Evidence
Caveats: Most reviewed sources rows are neutral facts or supporting article context rather than explicit positive evidence. Funding totals vary across articles (~$14.5M, $18.3M, ~$20M), so exact capitalization is uncertain |
| 25 | Globalstar lowweak | Opp 3 Risk 4 | Thesis: Risk is moderate because evidence coverage is absent inside the 90-day recent evidence window, making business-state, ownership, and catalyst timing uncertain for a 1 year+ ranking. Why now: There is effectively no why-now evidence in this row: the recent evidence review shows zero kept rows after the March 29, 2026 cutoff and no representative articles are provided. Caveats: The phase-2 rationale mentions Amazon acquisition-related articles, but those supporting articles are not included in the available evidence for this row. Scores remain low because absence of evidence is not positive evidence. |
| 26 | HyPrSpace lowweak | Opp 3 Risk 4 | Thesis: Risk is somewhat higher than opportunity because launch development is technically demanding and capital intensive, and the reviewed sources provide no available direct event evidence beyond the membership rationale to confirm de-risking milestones within the recent evidence window. Why now: The reviewed sources does not provide recent evidence window-supported article details for the cited raise and development milestones, so the timing case is under-evidenced. Caveats: No representative articles or direct evidence are available after recent evidence filtering. The opportunity view rests only on the membership rationale rather than article-level evidence available for citation. |
| 27 | Impulse Space mediummedium | Opp 8 Risk 4 | Thesis: Main risk is execution risk after a very large private financing round: the reviewed sources confirms capital raised, but does not provide within the recent evidence window direct evidence of completed commercial deployments or revenue realization. The article context says valuation was undisclosed, adding some uncertainty around terms and expectations. Why now: The catalyst is recent and dated: on June 2, 2026/June 3, 2026, Impulse Space disclosed a $500 million Series D and total capital raised above $1 billion, which is highly relevant for a 1 year+ scaling thesis. Evidence
Caveats: Some supportive items are supporting article context and should not be treated as independent confirmation if repeating the same financing announcement. Older commercial contract and government contract references in representative articles are outside the 90-day recent evidence window and therefore not primary recency support here. |
| 28 | Impulse Space lowweak | Opp 4 Risk 4 | Thesis: Risk is not based on direct adverse evidence; instead it reflects defense-program execution uncertainty and lack of currently available corroboration for program status, milestones, or revenue conversion, unavailable in reviewed sources). Why now: Why now is only medium because defense-space prototype work can matter over a 1 year+ horizon, but the reviewed sources' available evidence is empty after recent evidence window, preventing higher-conviction ranking. Caveats: No current evidence is provided for. No direct evidence remained after the recent evidence filter. Potential opportunity rests on membership rationale rather than available corroborated evidence. |
| 29 | Isar Aerospace mediummedium | Opp 5 Risk 4 | Thesis: Risk is also elevated because the same recent context ties the thesis to a near-term launch outcome and milestone execution; the opportunity appears highly contingent on launch success, making binary execution risk material over a 1 year+ horizon. Why now: Recent supporting article context within the recent evidence window supports timing: is dated June 9, 2026 and states Isar raised €270 million and had a June 15-21 Spectrum launch window from Andoya. Date basis is source date. Evidence
Caveats: Evidence is supporting article context only and appears under weak context, not direct dated events. Positive and risk interpretations come from the same article and are not independent confirmation. |
| 30 | ispace lowweak | Opp 3 Risk 4 | Thesis: Reviewed evidence rationale explicitly notes this is ispace's 'second attempt after 2023 failure,' which raises meaningful execution risk for a mission-driven thesis. With no direct positive or negative reviewed evidence, the prior failure context remains the clearest directional risk indicator in the reviewed sources. Why now: The membership support cites: and: The reviewed sources' wording around a second attempt makes mission outcome and execution durability relevant over a 1 year+ horizon, but timing confidence is reduced because no evidence survived into the available set. Caveats: Risk thesis is inferred from reviewed sources rationale mentioning a prior failure, not from available direct negative evidence. No direct evidence confirms current mission status, financing, or customer pipeline. Recency and sequencing of mission milestones cannot be validated from the empty evidence table. |
| 31 | Logos Space Services mediummedium | Opp 6 Risk 4 | Thesis: The same evidence implies substantial execution and engineering risk because the planned network is very large and would use higher-frequency K-, Q- and V-band spectrum that can improve capacity but also pose engineering challenges. Why now: A dated article within the 90-day recent evidence window, with based on April 13, 2026, states that Logos Space Services recently secured FCC approval for a constellation of up to 4,178 broadband satellites and described both target customers and technical architecture, making this a timely strategic-development signal for a 1 year+ horizon. Evidence
Caveats: Evidence is supporting article context, not a richer set of direct dated events/facts. Only one article after recent evidence window; same-article repeated rows are not independent confirmation. |
| 32 | Millennium Space Systems mediummedium | Opp 5 Risk 4 | Thesis: Risk remains moderate because the reviewed sources only provides supporting article context, not direct contract economics, scope allocation to Millennium, or follow-on execution milestones. Why now: The relevant evidence is within the recent evidence window: an April 8, 2026 article said the U.S. Space Force awarded 14 companies more than $1.8 billion in Andromeda contracts and included Boeing's Millennium Space Systems, which is potentially durable over a 1 year+ horizon if tasking converts into meaningful work Evidence
Caveats: Evidence is supporting article context, not a company-specific contract award document or structured positive event row. Reviewed evidence does not show Millennium's individual award size or share of the ceiling value. Same article repeated in weak-context rows is not independent confirmation. |
| 33 | NewOrbit Space mediummedium | Opp 4 Risk 4 | Thesis: Risk is also meaningful because the evidence is undated supporting article context, so recency is uncertain; for a business-state claim like financing and current program maturity, lack of date makes it harder to assess whether the capital raise is still a live catalyst or already absorbed. Why now: Why now is weaker than Aavuus because the article has no publication date. The reviewed sources explicitly says no is available and recency-sensitive claims should be treated cautiously., undated Evidence
Caveats: Evidence is supporting article context only, not direct structured positive event evidence. Publication date is unavailable; recency is uncertain. Single-article support only; no independent confirmation. |
| 34 | NordSpace lowweak | Opp 2 Risk 4 | Thesis: Main risk is evidence insufficiency and likely execution uncertainty around an early-stage space venture rather than confirmed adverse developments; the reviewed sources contain no available direct negative evidence within the recent evidence window and no current dated business-state confirmation, unavailable in reviewed sources). Why now: Why now is weak because coverage data shows zero articles after recent evidence window and zero evidence after the 90-day filter, so there is no current catalyst evidence to support a 1 year+ differentiated view from these reviewed sources. Caveats: No article is provided for the membership-support. No direct positive or negative evidence were available after recent evidence window. Private-company status reduces external validation in these reviewed sources. |
| 35 | NorthStar Earth & Space Inc. lowweak | Opp 2 Risk 4 | Thesis: This row carries elevated information risk because the reviewed sources show no recently retained evidence, no representative articles, and no direct positive or negative evidence, while the ticker/public status implications are time-sensitive and unsupported here. Why now: Why-now is weak because the evidence recent evidence review shows zero kept rows after the 90-day cutoff and the row contains no representative articles or direct evidence, so recency and business state are uncertain in these reviewed sources. Caveats: No evidence were available after the recent evidence window for this row. Any statement about public listing, SPAC timing, or operations would be insufficiently grounded from this row alone. Score is driven by evidence absence, not by documented adverse developments. |
| 36 | Northwood Space mediumweak | Opp 6 Risk 4 | Thesis: Risk is still moderate because the visible reviewed sources does not include the underlying article summary or, so the funding signal lacks fuller context such as use of proceeds, valuation, or milestone cadence. Why now: The rationale references article: and states Northwood Space raised $100 million in a notable spacetech funding deal; that size of financing is plausibly durable over a 1 year+ horizon, though recency cannot be fully validated from the absent article body. Caveats: No representative article or provided in the visible evidence body. No direct evidence after recent evidence window are exposed despite the positive rationale. Funding alone does not prove technical or commercial execution. |
| 37 | Obruta Space Solutions lowweak | Opp 4 Risk 4 | Thesis: Current risk is equal to opportunity because the reviewed sources only shows descriptive company-site context and no direct evidence of contracts, funding, launches, or technical milestones. Without validation, the thesis is still conceptual. Why now: The only dated visible evidence is a company-site page with a May 20, 2026 describing the technology and target markets, which is relevant for strategic positioning but not enough to prove commercial inflection within the next year. Evidence
Caveats: Evidence is company-site descriptive context only. No third-party validation, financing, contract, or deployment evidence is shown. |
| 38 | Observable Space lowweak | Opp 4 Risk 4 | Thesis: The reviewed sources provide no direct operating-niche detail, traction, or milestone evidence beyond the funding mention, so execution risk is relatively elevated despite the financing signal. Why now: Why now is the funding mention tied to article ID: but the reviewed sources provide no, operating specifics, or additional corroborating evidence. Caveats: Funding alone is positive evidence but does not prove business quality. Article ID: is referenced without. |
| 39 | Observable Space mediummedium | Opp 8 Risk 4 | Thesis: Risk remains meaningful because most evidence is supporting source context and neutral facts rather than explicit positive events, and the company still appears to be early-stage, contract-execution dependent, and private. Why now: The timing is favorable because on May 28, 2026 the company was reported to have both closed a $90 million Series A and announced a $94 million U.S. Space Force award, with additional follow-on reporting on June 9, 2026 indicating the contract landed just weeks after the raise, suggesting a recent step-change in funding and government traction for a 1 year+ horizon Evidence
Caveats: Positive direction is inferred from neutral facts plus article summaries; the reviewed sources does not provide explicit positive events. Same-article repeated rows are not independent confirmation. Supporting web-search evidence is context and should be treated below directly cited company evidence. |
| 40 | OMSPACE lowweak | Opp 4 Risk 4 | Thesis: Launch development risk is also high because the evidence only shows an early milestone and a future plan for orbital launch capability by 2027. The reviewed sources contain no retained proof of financing, customer backlog, or follow-on technical milestones, so execution risk is substantial. Why now: The reviewed sources' rationale references article: for a successful sounding-rocket launch and a 2027 orbital-launch target, but the underlying article summary/ is not included here, limiting recency and sequence assessment. Caveats: Evidence is limited to a broad membership rationale without article detail. A sounding-rocket success is meaningfully earlier-stage than an orbital launch business. Risk and opportunity are both elevated relative to peers because the technology path is ambitious but still lightly evidenced. |